HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Leukocytapheresis for the treatment of refractory Henoch-Schönlein purpura resistant to both prednisolone and intravenous immunoglobulin therapy.

Abstract
Henoch-Schönlein purpura (HSP) is a childhood disorder, which is the vasculitis of systemic small vessels of unknown etiology. We encountered the dramatic efficacy of leukocytapheresis in a Japanese girl with refractory HSP resistant to combined prednisolone plus intravenous immunoglobulin therapy administration.
AuthorsEishin Oki, Koji Tsugawa, Koichi Suzuki, Etsuro Ito, Hiroshi Tanaka
JournalRheumatology international (Rheumatol Int) Vol. 28 Issue 11 Pg. 1181-2 (Sep 2008) ISSN: 0172-8172 [Print] Germany
PMID18509652 (Publication Type: Case Reports, Letter)
Chemical References
  • Anti-Inflammatory Agents
  • Immunoglobulins, Intravenous
  • Immunologic Factors
  • Prednisolone
Topics
  • Anti-Inflammatory Agents (therapeutic use)
  • Child, Preschool
  • Female
  • Humans
  • IgA Vasculitis (drug therapy, therapy)
  • Immunoglobulins, Intravenous (therapeutic use)
  • Immunologic Factors (therapeutic use)
  • Leukapheresis
  • Prednisolone (therapeutic use)
  • Treatment Failure

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: